CDE Catalog

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Displaying 726 - 750 of 755
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Subdisease Name
C60369 Serious adverse event site aware date and time

Date (and time, if applicable and known) on which the site first became aware of the serious adverse event

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60370 Serious adverse event ongoing indicator

Indicator of whether the serious adverse event experienced by the participant is ongoing

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60371 Serious adverse event result death indicator

Indicator of whether the serious adverse event resulted in death

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60372 Serious adverse event threaten life indicator

Indicator of whether the serious adverse event is life threatening

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60373 Serious adverse event initial prolong hospital indicator

Indicator of whether the serious adverse event resulted in initial or prolonged hospitalization for the participant

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60374 Serious adverse event intervention require prevent permanent impairment damage indicator

Indicator of whether the serious adverse event required intervention to prevent permanent impairment or damage

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60375 Serious adverse event result persistent significant disability incapacity indicator

Indicator of whether the serious adverse event resulted in persistent or significant disability or incapacity

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60376 Serious adverse event associate congenital anomaly birth defect indicator

Indicator of whether the serious adverse event is associated with a congenital anomaly or birth defect

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60377 Serious adverse event other important medical event indicator

Indicator of whether the serious adverse event is a medically important event not covered by other 'serious' criteria

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60378 Serious adverse event other important medical event text

The free-text field to describe the medically important event not covered by other 'serious' criteria

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60379 Study intervention name

Name of study intervention

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60380 Serious adverse event cause discontinue study indicator

Indicator of whether the serious adverse event caused the participant to be discontinued from the study

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60381 Serious adverse event investigator assessment reason other text

The free-text field related to 'Serious adverse event investigator assessment reason', specifying other text. Reason in the opinion of the principal investigator that is attributed as the cause of the serious adverse event

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60382 Principal investigator name

Name of principal investigator

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60383 Principal investigator address text

The free-text field to specify the principal investigator's address

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60384 Adverse event report identifier telephone number

Telephone number of an authorized group or person reporting the adverse event

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60385 Serious adverse event sponsor assessment indicator

Indicator of whether the adverse event is serious, based on the sponsor's assessment

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C60386 Adverse event site aware date and time

Date (and time, if applicable and known) on which the site first became aware of the adverse event

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C60387 Adverse event ongoing indicator

Indicator of whether the adverse event experienced by the participant is ongoing

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C60388 Adverse event severity intensity CDISC grade

Grade of severity or intensity of the adverse event according to the Clinical Data Interchange Standards Consortium (CDISC) terminologies

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C60389 Adverse event study intervention action take type other text

The free-text field related to 'Adverse event study intervention action take type', specifying other text. Type of action taken for adverse event in relation to study intervention

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C00004 Birth country ISO code

Code (ISO 3166-1 alpha-2 code) for country where the participant was born

Supplemental Demographics General (For all diseases) General (For all diseases)
C00005 Birth country name

Name for country where the participant was born

Supplemental Demographics General (For all diseases) General (For all diseases)
C12611 Birth location state name

Name of the state/province/similar political division in which participant was born

Supplemental Demographics General (For all diseases) General (For all diseases)
C18385 Birth time

Time the participant was born

Supplemental Demographics General (For all diseases) General (For all diseases)
Displaying 726 - 750 of 755

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.